Investigating the correlation of the NF-κB and FoxP3 gene expression with the plasma levels of pro- and anti-inflammatory cytokines in rheumatoid arthritis patients
- PMID: 36737515
- DOI: 10.1007/s10067-023-06521-y
Investigating the correlation of the NF-κB and FoxP3 gene expression with the plasma levels of pro- and anti-inflammatory cytokines in rheumatoid arthritis patients
Abstract
Introduction: Rheumatoid arthritis (RA) is a chronic inflammatory systemic autoimmune disease. Cytokines regulate a wide range of inflammatory processes involved in RA pathogenesis. Anti-inflammatory cytokines (i.e., TGF-β and lL-10) and pro-inflammatory cytokines, like IL-6, were found to be potentially implicated in RA pathogenesis. Besides, NF-κB and FoxP3 are critical transcription factors regulating the inflammatory events occurring in RA patients. This study intends to assess the plasma levels of IL-6, IL-10, and TGF-β1 cytokines, as well as the expression of NF-κB and FoxP3 genes in RA patients, compared to the healthy controls.
Methods: Peripheral blood was collected from 50 RA patients (25 new case and 25 under-treatment) and 25 age- and gender-matched healthy subjects. The disease activity was determined using the DAS-28 and ESR criteria. Also, plasma levels of TGF-β1, lL-10, and IL-6 were measured by enzyme-linked immunosorbent assay (ELISA) technique, and the gene expression of NF-κB and FoxP3 was evaluated using the real-time PCR method.
Results: Our results showed a significant up-regulation of Rel-A and NF-κB1, and also a down-regulation of FoxP3 gene expression in under-treatment RA patients compared to the controls (P=0.031, P=0.014, and P=0.011, respectively). Moreover, there was a significant reduction of Rel-A and FoxP3 in the under-treatment RA patients compared to new case RA patients (P=0.005 and P=0.015, respectively). Also, plasma levels of TGF-β1 were significantly increased in both the new case and under-treatment RA patients relative to controls (P<0.001).
Conclusion: In conclusion, classical NF-κB (P65/P50) and FoxP3 may have significant pro- and anti-inflammatory roles in RA pathogenesis, respectively. Key Point • NF-κB (P65/P50) has a contribution to the early phase of RA.
Keywords: FoxP3; NF-κB; Regulatory T cell; Rheumatoid Arthritis; TGF-β1.
© 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Similar articles
-
Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression.Inflammopharmacology. 2024 Dec;32(6):3687-3695. doi: 10.1007/s10787-024-01565-1. Epub 2024 Sep 4. Inflammopharmacology. 2024. PMID: 39231852
-
The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.Immunopharmacol Immunotoxicol. 2020 Jun;42(3):228-236. doi: 10.1080/08923973.2020.1742734. Epub 2020 Mar 29. Immunopharmacol Immunotoxicol. 2020. PMID: 32223462 Clinical Trial.
-
Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.Immunol Lett. 2006 Jun 15;105(2):159-66. doi: 10.1016/j.imlet.2006.02.003. Epub 2006 Mar 3. Immunol Lett. 2006. PMID: 16564576
-
The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.Arthritis Res Ther. 2008;10(4):212. doi: 10.1186/ar2457. Epub 2008 Aug 21. Arthritis Res Ther. 2008. PMID: 18771589 Free PMC article. Review.
-
Targeting transcription factors for therapeutic benefit in rheumatoid arthritis.Front Immunol. 2023 Jun 29;14:1196931. doi: 10.3389/fimmu.2023.1196931. eCollection 2023. Front Immunol. 2023. PMID: 37457726 Free PMC article. Review.
Cited by
-
Elevation of IL-8 secretion induced by PEDV infection via NF-κB signaling pathway.Front Cell Infect Microbiol. 2024 Jul 22;14:1422560. doi: 10.3389/fcimb.2024.1422560. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39104852 Free PMC article.
-
Rheumatoid arthritis and diabetic retinopathy: A two-sample Mendelian randomization study.Medicine (Baltimore). 2024 Jul 26;103(30):e39001. doi: 10.1097/MD.0000000000039001. Medicine (Baltimore). 2024. PMID: 39058858 Free PMC article.
-
Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression.Inflammopharmacology. 2024 Dec;32(6):3687-3695. doi: 10.1007/s10787-024-01565-1. Epub 2024 Sep 4. Inflammopharmacology. 2024. PMID: 39231852
References
-
- Alunno A, Manetti M, Caterbi S, Ibba-Manneschi L, Bistoni O, Bartoloni E, Valentini V, Terenzi R, Gerli R (2015) Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications. Mediators Inflamm 2015:751793. https://doi.org/10.1155/2015/751793 - DOI - PubMed - PMC
-
- Alunno A, Carubbi F, Giacomelli R, Gerli R (2017) Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets. BMC Rheumatol 1:3. https://doi.org/10.1186/s41927-017-0001-8 - DOI - PubMed - PMC
-
- Roman-Blas JA, Jimenez SA (2006) NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 14(9):839–848. https://doi.org/10.1016/j.joca.2006.04.008 - DOI - PubMed
-
- Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113(9):1271–1276. https://doi.org/10.1172/jci20945 - DOI - PubMed - PMC
-
- Scott-Taylor TH, Hourihane JB, Harper J, Strobel S (2005) Patterns of food allergen-specific cytokine production by T lymphocytes of children with multiple allergies. Clin Exp Allergy 35(11):1473–1480. https://doi.org/10.1111/j.1365-2222.2005.02355.x - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous